Dova Pharmaceuticals Inc logo

DOVA - Dova Pharmaceuticals Inc News Story

$28.04 0.0  0.0%

Last Trade - 11/11/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £9.77m
Position in Universe th / 6856

BRIEF-Dova Pharmaceuticals Inc - For Q2 Of 2018, Dova Reported Net Product Sales From Doptelet Of $2.0 Million

Thu 9th August, 2018 9:12pm
Dova Pharmaceuticals Inc  DOVA.O :
    * DOVA PHARMACEUTICALS REPORTS SECOND QUARTER 2018 OPERATING
AND
FINANCIAL RESULTS
    * DOVA PHARMACEUTICALS INC - DOVA REPORTED A NET LOSS OF
$20.0
MILLION FOR Q2 OF 2018, COMPARED TO A NET LOSS OF $5.5 MILLION
FOR SAME PERIOD IN 2017
    * DOVA PHARMACEUTICALS INC - FOR Q2 OF 2018, DOVA REPORTED
NET
PRODUCT SALES FROM DOPTELET OF $2.0 MILLION
    * DOVA PHARMACEUTICALS INC - AS OF JUNE 30, 2018, DOVA HAD
$134.7
MILLION IN CASH AND EQUIVALENTS COMPARED TO $94.8 MILLION AS OF
DECEMBER 31, 2017

Source text for Eikon:  ID:nGNX1fXNDF 
Further company coverage:  DOVA.O
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.